Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans?
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The metabolic syndrome (MetS) is highly prevalent in the growing U.S. Latino population. We hypothesize that MetS, with or without diabetes, is associated with progressive disability in older Mexican Americans. METHODS: Data from Mexican Americans 60-98 years old participating in the Sacramento Area Latino Study on Aging (SALSA) were analyzed from baseline through 3 years (3 years of follow-up). Disability was assessed by self-reported limitations in activities of daily living (ADLs), instrumental ADLs (IADLs), and mobility/strength tasks. MetS (46% of sample) was defined by National Cholesterol Education Program (NCEP) Adult Treatment Panel III criteria. Diabetes (DM, 33%) was defined by fasting blood sugar>125 mg/dL, physician diagnosis, and/or medication use. Four metabolic groups were defined: MetS with diabetes (MetS+DM+, n=402); MetS without diabetes (MetS+DM-, n=330); diabetes without MetS (MetS-DM+, n=125); and neither (MetS-DM-, n=749). Generalized estimating equation (GEE) regression models were used to evaluate the effect of metabolic group on physical limitations and disability changes over time. RESULTS: Diabetes, with or without MetS, was associated with a higher percent rate of increase over 3 years in ADL and IADL disability than was no diabetes, even after controlling for demographics, body mass index (BMI), and incident disease. The mean ADL score had a 35% higher rate of increase (higher = more impairment) for the MetS+DM+ group and 68% higher for the MetS-DM+ group. Results for IADL were similar. The baseline MetS, without or with diabetes, was associated with a significantly higher rate of increase in mobility/strength limitations (8% and 36.5%, respectively). CONCLUSIONS: In older Mexican Americans, MetS is associated with progressive limitations in mobility and strength. Preventing progressive mobility/strength limitations may require assessing and treating these impairments in people with MetS regardless of the presence of diabetes. However, preventing the progression of MetS without to MetS with diabetes may be important to limit the progression of ADL and IADL disability found in people with MetS and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Haan, M. N., Mungas, D. M., Gonzalez, H. M., Ortiz, T. A., Acharya, A., & Jagust, W. J. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51054.x · Cited by 420
Self-citationHu, G., Lindström, J., Valle, T. T., Eriksson, J. G., Jousilahti, P., Silventoinen, K., Qiao, Q., & Tuomilehto, J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.8.892 · Cited by 340
Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1195 · Cited by 312
Metabolic and Inflammation Variable Clusters and Prediction of Type 2 Diabetes
Hanley, A. J. G., Festa, A., D’Agostino, R. B., Wagenknecht, L. E., Savage, P. J., Tracy, R. P., Saad, M. F., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1773 · Cited by 198
McNeill, A. M., Rosamond, W. D., Girman, C. J., Heiss, G., Golden, S. H., Duncan, B. B., East, H. E., & Ballantyne, C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.107 · Cited by 177
Najarian, R. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.1.106
Cited by
Cadore, E. L., & Izquierdo, M. (2015) · AGE · doi:10.1007/s11357-015-9800-2 · Cited by 93
“The many complications associated with diabetes include cardiovascular diseases, peripheral neuropathy, retinopathy, chronic renal failure, and impaired mental health (Blaum et al. 2007; Maiorana et al. 2002; Reeves et al. 2010), which put diabetic patients in a polypathological condition (i.”
BackgroundPark, S., Park, H., Togo, F., Watanabe, E., Yasunaga, A., Yoshiuchi, K., Shephard, R. J., & Aoyagi, Y. (2008) · The Journals of Gerontology: Series A · doi:10.1093/gerona/63.10.1119 · Cited by 70
“Such activity may reduce the risk of functional impairment and disability commonly found in older individuals with metabolic syndrome ( 16 ).”
BackgroundAging and disability among Hispanics in the United States: current knowledge and future directions
Garcia, M. A., Downer, B., Crowe, M., & Markides, K. S. (2017) · Innovation in Aging · doi:10.1093/geroni/igx020 · Cited by 48
Metadata
- Authors
- Blaum, C. S., West, N. A., & Haan, M. N.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-01
- Volume
- 62
- Issue
- 7
- Pages
- 766-773
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2117145330
- Cited by
- 47
- References
- 8
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans? https://app.cochat.ai/papers/10.1093/gerona/62.7.766
- The paper
- Blaum, C. S., West, N. A., & Haan, M. N. (2007). Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans? The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/62.7.766
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.